Managing Moderate To Severe Cases Of Canine Atopic Dermatitis

Original Presentation Date:
08/19/2025

$20 - $50 (Non-CE / CE Eligible)
Free for Premium Membership subscribers

In this second webinar on the topic of canine atopic dermatitis, Dr. Pieper continues his discussion with a focus on moderate to severe cases of disease. His discussion includes:

  • Characteristics of moderate to severe disease
  • Current therapeutic options including JAK inhibitors (Apoquel and Zenrelia) and when they should be implemented into treatment plans
  • The role of monoclonal antibodies and how Cytopoint can be used as part of patient management
  • The ideal cases for allergen specific immunotherapy and testing options


Running time: 1 hr 16 mins (including 16 mins of Q&A)
Approved for 1 hour of CE credit by AAVSB RACE and NY State

You might also like

Improving The Quality Of Life For Cats With Chronic Kidney Disease

09/23/2025

Chronic kidney disease (CKD) is one of the most common and challenging conditions affecting older ca...

Read More

Stem Cell Therapy For Canine Atopic Dermatitis

08/20/2025

Canine atopic dermatitis is a complex disease. Management of patients is often multimodal and includ...

Read More

Canine Atopic Dermatitis - Pathogenesis, Diagnosis, And Treatment Of Mild Disease

08/12/2025

Canine atopic dermatitis (CAD) is one of the most frustrating and complex skin conditions encountere...

Read More

The Skinny On Pyoderma - The Most Common Bacterial Infection Of The Skin

08/05/2025

Pyoderma (bacterial skin infection) is one of the most common dermatologic conditions seen in compan...

Read More

Tackling Itchy And Smelly Ears

07/29/2025

Otitis externa is a common and often recurrent condition affecting the ears of dogs and cats. The co...

Read More

Supporting The Cancer Patient: Managing Cancer Pain, Nutritional Needs Of Patients, And Supporting The Caregiver Through It All

12/04/2024

Aside from the plan prescribed to treat a pet’s cancer, we have to ensure that we are addressi...

Read More